By allowing ads to appear on this site, you support the local businesses who, in turn, support great journalism.
Federal study gives new options for people with rare cancers
Results suggest that for people with unusual diseases, there seems to be a way to predict who will – and will not – benefit from a drug combo that boosts the immune system
rare cancers.jpg
This March 12, 2019, photo provided by Brigitte Sagasser shows her in San Marcos, Calif. Sagasser, a participant in a federal study for rare cancers, seems to be benefitting from the treatment. Her tumors have been shrinking since starting the treatment a year ago for a rare type of ovarian cancer that defied surgeries, chemotherapy and hormone therapy. (Courtesy Brigitte Sagasser via AP)
ATLANTA — People with rare cancers have been out of luck — not only do most lack good treatments but drug companies also don't pursue them because of small potential sales. Now, a federal study that pools these folks gives them strength in numbers and new options.
Sign up for the Herald's free e-newsletter